We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$448M
AUM Growth
+$22.8M
Cap. Flow
+$6.71M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.81%
Holding
124
New
3
Increased
44
Reduced
55
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.59M
2
NKE icon
Nike
NKE
+$1.05M
3
SBUX icon
Starbucks
SBUX
+$630K
4
ADBE icon
Adobe
ADBE
+$498K
5
V icon
Visa
V
+$355K

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$894K
2
FMER
FIRSTMERIT CORP
FMER
+$433K
3
GLW icon
Corning
GLW
+$398K
4
CPB icon
Campbell Soup
CPB
+$279K
5
CVS icon
CVS Health
CVS
+$256K

Sector Composition

Rank Sector Weight
1 Healthcare 18.16%
2 Technology 16.92%
3 Communication Services 13.14%
4 Industrials 12.4%
5 Consumer Staples 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
101
Regeneron Pharmaceuticals
REGN
$78.5B
$345K 0.08%
+859
New +$345K
MPC icon
102
Marathon Petroleum
MPC
$92.4B
$271K 0.06%
6,700
– –
LOW icon
103
Lowe's Companies
LOW
$117B
$260K 0.06%
3,605
– –
MON
104
DELISTED
Monsanto Co
MON
$253K 0.06%
2,485
– –
HBAN icon
105
Huntington Bancshares
HBAN
$34.4B
$251K 0.06%
+25,540
New +$243K
BAC icon
106
Bank of America
BAC
$435B
$245K 0.05%
15,655
– –
VTRS icon
107
Viatris
VTRS
$20.4B
$243K 0.05%
6,390
-915
-13% -$40.7K
PCG icon
108
PG&E
PCG
$38.3B
$241K 0.05%
3,946
-160
-4% -$10.2K
MAS icon
109
Masco
MAS
$14.1B
$239K 0.05%
6,975
– –
MET icon
110
MetLife
MET
$61.9B
$227K 0.05%
5,739
– –
KR icon
111
Kroger
KR
$35.4B
$210K 0.05%
7,096
– –
PX
112
DELISTED
Praxair Inc
PX
$203K 0.05%
1,685
-200
-11% -$23.7K
CPB icon
113
Campbell Soup
CPB
$6.55B
– –
-4,200
Closed -$279K
CTSH icon
114
Cognizant
CTSH
$24.9B
– –
-3,900
Closed -$223K
CVS icon
115
CVS Health
CVS
$133B
– –
-2,676
Closed -$256K
HAIN icon
116
Hain Celestial
HAIN
$45M
– –
-17,975
Closed -$894K
FMER
117
DELISTED
FIRSTMERIT CORP
FMER
– –
-21,375
Closed -$433K
1 2 3 4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs & Co held 124 positions worth $448M, up 5.4% from $426M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jacobs & Co's Q3 2016 filing shows 3 new, 44 increased, 55 reduced and 5 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 859 shares worth $345K. The largest sale was Hain Celestial, an estimated $894K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Communication Services.

  • Jacobs & Co's largest Q3 2016 buy was Regeneron Pharmaceuticals: 859 shares worth $345K.
  • Jacobs & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q3 2016 reduction was Corning, cutting an estimated $398K.
  • Jacobs & Co fully exited Hain Celestial in Q3 2016, selling an estimated $894K.
  • Jacobs & Co's ten largest holdings make up 22% of its $448M portfolio in Q3 2016.
  • Jacobs & Co opened 3 new positions and closed 5 in Q3 2016.
  • Jacobs & Co's portfolio value rose 5.4% quarter-over-quarter to $448M.

Based on Jacobs & Co's 13F filing for Q3 2016, filed 11 Oct 2016.